Congo trial of Ebola treatments switches to focus on two drugs

A clinical trial of four potential Ebola treatments in Congo has been narrowed to focus on two of the experimental drugs - Regeneron's REGN-EB3 and a monoclonal antibody called mAb114 - after they showed encouraging results, scientists leading the trial said on Monday.

from Reuters: Health News https://ift.tt/2H3XkxA
via IFTTT